Exchange: OTC·Updated 03:50 PM EDT

ADAPY Adaptimmune Therapeutics Plc - ADR

$0.03
$0.002
(7.14%)
Today
Reported EarningsAug 13
Mkt Cap$7.95M
Vol77,349.00

About ADAPY

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
30

Bearish Sentiment

How do you feel about ADAPY?

US_Bull
$ADAPY Strong approved finish and strong day closing at the highs after 46% rocket yesterday. Continuation tomorrow.
22
US_Bull
$ADAPY Absolutely bonkers swing of 3,800% intraday. Let us hope we can very soon kiss this ticker our final goodbyes.
18
US_Bull
$ADAPY I have previously mentioned multiple times that the lete-cel BLA may already have been filed months ago and it may be in regulatory review, because of from LI, "Led Pre-Approval Inspection (PAI) readiness for US and UK clinical sites supporting the lete-cel BLA submission — both sites received No Action Indicated (NAI), the highest possible FDA and MHRA regulatory outcome." The PAI is done at the final stages of regulatory review and they received NAI. The only argument speaking against this is that person is mentioning a 'mock' FDA and MHRA simulation in-house meaning the sites go through an audit of how an FDA and MHRA would really look like. Assuming it has been filed, I was thinking the rise of market cap this week ~4 million could be a reflection of MS payments for lete-cel. In any event, once lete-cel is approved likely in Q1, 2027 or with delays in Q2 an additional 10 million is guaranteed.
2
8
PaidPiper
$ADAPY not only did we break out Wednesday but more importantly we gave none if it back. Primed for continuation next week 👍🏼
10
PaidPiper
$ADAPY it's better to be optimistic and wrong than pessimistic and right. I just made that up, any good? Might get it tattooed across my forehead 🤔
8
PaidPiper
$ADAPY they are GMT time zone but only trades on the US market. So news will eventually drop in accordance to US premarket time (8am-930am)
8
Hodl707
$ADAPY have a good weekend yall !! Monday could be the day ! Or Tuesday ! Weds ! Thur fri!! Lol ! Drink some whisky 🥃 it helps !
8
duepillagence
$ADAPY This establishes that adapy already has a clinically validated IT cell product (that's MAGE-A4 specific)!! Anyone care to DD it's current valuation!!! Disclaimer: I already have 🤑
1
5
Hodl707
$ADAPY The "no updates" compliance paperwork filed today successfully checked the box to keep the entity clean, and the order book is responding exactly how a pre-payout shell should. Sit back, ignore the daily micro-fluctuations, and let the clock run out toward the December finale
1
5
michele3
$ADAPY Everyone is doing great job at finding out all pertaining things. But the reality is that we’re trading @ 0.02 and we haven’t got any news in months. Seems like smoking mirrors
2
2
DLORE
$ADAPY bid to ask is a 95% gap at close (~50% from the actual close price), a nearly 250,000 share block going through today. We’re there…
6
Ttubular
$ADAPY very high high volume almost 10x the avg!! Bid-ask spread is large. .028 x .0393. That’s crazy on a penny stock. Something must be brewing!!!
7
duepillagence
$ADAPY If an bottleneck, low scalable modality (that was our divested therapies) almost sold for $ 100 mil ($85 mil w milestones to be exact) how much more can a allogeneic hIPSC universal modality go for? 🤔
7
duepillagence
$ADAPY Just thought I'd share. Adaptimmune's PATENT on their hIPSC platform. The patent is perpetually protected no matter which TCR they key into iT cells:
7
Hodl707
$ADAPY even though we had almost 500 K in volume today, no large blocks, no medium-size blocks, just small blocks sold. What’s that tell you? The proof is in the pudding
7
NexDollar
$ADAPY This is an event-driven stock, where its price is likely only primarily to be influenced by the possibility of a catalyst or major news event, rather than by ordinary day-to-day trading. Given the thin trading and wide spreads, normal price-discovery assumptions simply cannot reliably apply on most days.
6
NexDollar
$ADAPY Despite what we already knew about the usefulness of their cutting-edge biomedical technologies and the many patients in need of their potentially life-saving therapies, the market is only now beginning to recognize their commercial value.
6
manny11419
$ADAPY So the company $30 mill. cash balance is earning around 5%, the $1.5 million interest, is more than enough to pay the eight remaining employees until the end game....and I believe we'll get an additional $5 mill by YE. Waiting is so bad after all.
6
HellasManN10
$ADAPY These latest observations are interesting; I’ve read them carefully. Two things, dear US_Bull: 1. Could you raise the target a little bit? Come on! ... 2. I hope the "Caribbean plan" hasn't been abandoned ... Warm regards.
1
3
ricoti
$ADAPY Still following MB. Hoping for the best for all the longs. Tried to buy a small position and was paying the ask,but didn't fill. Tomorrow.
6

Advertisement|Remove ads.